Clinical Trial: Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)

U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07473804) titled 'Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)' on March 11.

Brief Summary: Neonatal salt loss can be caused not only by infections but also by rare endocrine disorders that resemble 21-hydroxylase deficiency but are not detected by neonatal screening. This study examines how often these conditions occur and describes their main clinical, genetic, and treatment features.

Study Start Date: April 14, 2025

Study Type: OBSERVATIONAL

Condition: Neonatal Salt Loss Congenital Adrenal Hyperplasia (CAH)

Recruitment Status: RECRUITING

Sponsor: IRCCS Azienda Ospedal...